Latest filing published 26 Oct 2018 for U.S. Stem Cell, Inc., €12k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -66.1%Entry US$590.00 · Close at T+365 US$200.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Mark P. Borman: trading record in brief
Mark P. Borman is a declared insider of U.S. Stem Cell, Inc., with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 26 February 2010 to 19 October 2018.
The open-market record is one-sided, with 1 purchase worth €9,978 and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 26 October 2018: a transaction of €12k, in U.S. Stem Cell, Inc. The last insider purchase was made public on 3 March 2010, 6,094 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark P. Borman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 526,918 shares@ US$0.027Common StockSEC:0001185185-18-001879:0
- 23,450 shares@ US$0.58Common StockSEC:0001388431-10-000012:0Canonical exit: 27 May 2010 (T+90)
2 of 2 declarations